Oxcarbazepine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65162-649 -
Package NDC
65162-649-48 -
Package NDC
65162-649-78 -
Application number
ANDA202961 -
SPL ID
1ec65e90-ec0e-431f-a985-d7cb39694492 -
SPL set ID
2515391e-3a88-4226-92e5-f641c8409fe5 -
UNII
VZI5B1W380 -
RxCUI
283536
What the source publishes
- Labeler
- Amneal Pharmaceuticals LLC
- Active ingredients
- Oxcarbazepine
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Oxcarbazepine",
"splId": "1ec65e90-ec0e-431f-a985-d7cb39694492",
"labels": [
{
"setId": "2515391e-3a88-4226-92e5-f641c8409fe5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2515391e-3a88-4226-92e5-f641c8409fe5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2515391e-3a88-4226-92e5-f641c8409fe5"
}
],
"routes": [
"ORAL"
],
"labeler": "Amneal Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 CUP, UNIT-DOSE in 1 TRAY (65162-649-48) / 5 mL in 1 CUP, UNIT-DOSE (65162-649-43)",
"package_ndc": "65162-649-48",
"identifierStatus": "well-formed",
"marketing_start_date": "20120604"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (65162-649-78) / 250 mL in 1 BOTTLE",
"package_ndc": "65162-649-78",
"identifierStatus": "well-formed",
"marketing_start_date": "20120604"
}
],
"productId": "65162-649_1ec65e90-ec0e-431f-a985-d7cb39694492",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "65162-649",
"deaSchedule": null,
"genericName": "Oxcarbazepine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OXCARBAZEPINE",
"strength": "300 mg/5mL"
}
],
"applicationNumber": "ANDA202961",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120604",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486"
],
"upc": [
"0365162649789"
],
"unii": [
"VZI5B1W380"
],
"rxcui": [
"283536"
],
"spl_set_id": [
"2515391e-3a88-4226-92e5-f641c8409fe5"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]"
],
"manufacturer_name": [
"Amneal Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65162-649_1ec65e90-ec0e-431f-a985-d7cb39694492"